Figure 2 presents a timeline of GLP- 1 discovery and clinical development
Push the plunger slightly to expel the air back into the vial
Subject to draft guidance being made permanent, tirzepatide is the first weight-loss drug recommended by NICE to be prescribed directly by GPs, for patients with a BMI over 35kg/m2 and one weight-related comorbidity
You will notice an increase in energy levels when you use these shots and find that they can help promote quick fat loss
Furthermore, the effects of GLP-1 on HF, especially established/symptomatic HF, are poorly understood and has been a subject of active debate [6,7,8,9]
Post-marketing pharmacovigilance data do not exist